Furthermore, because BRIP1 was originally identified in research on Fanconi anemia (FANCJ; OMIM #609054) [73], the NCCN clinical practice guidelines in oncology recommend counseling BRIP1 GPV carriers about the risk of autosomal recessive conditions in their offspring [46]. The gene discussed is BRIP1; the disease is anemia.